“EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED REFRACTORY NON-SMALL CELL LUNG CANCER: INTERIM RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY”. Voprosy onkologii 65, no. 1 (January 1, 2019): 99–105. Accessed October 15, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/931.